| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 30/09/2009 | 12h13 | Marketwired | RidgewaterEquity.com Free Fundamental Sector & Market Research on KCI, ARW, MRX, PSYS, OCLS and ANPI | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 22/09/2009 | 20h20 | PR Newswire (US) | Angiotech Pharmaceuticals announces TAXUS(R) Libert (R) Stent continues to demonstrate significant improvements over TAXUS(R) Ex | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 02/09/2009 | 21h30 | PR Newswire (US) | Angiotech's corporate partner, Boston Scientific, reports two-year SYNTAX data showing comparable safety outcomes for complex pa | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 02/09/2009 | 12h24 | Marketwired | BenchmarkJournal.com Free Analyst Review for BBBY, NVDA, AMSC, BEAT, SBUX and ANPI | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 01/09/2009 | 02h05 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 20/08/2009 | 14h30 | PR Newswire (US) | Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 20/08/2009 | 12h21 | Marketwired | TheFortuneFinancial.com Free Market Research on CROX, AMSC, CINF, EXEL, HANS and ANPI | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 19/08/2009 | 22h48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 14/08/2009 | 23h27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 14/08/2009 | 23h15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 14/08/2009 | 23h09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 13/08/2009 | 18h54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 13/08/2009 | 18h48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 13/08/2009 | 14h30 | PR Newswire (US) | Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil | NASDAQ:ANPI | |
| 11/08/2009 | 14h00 | PR Newswire (US) | Angiotech's Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 07/08/2009 | 23h26 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 06/08/2009 | 16h54 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 06/08/2009 | 14h30 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 06/08/2009 | 13h26 | Marketwired | WallStSense.com Fundamental & Technical Coverage of CLWR, HERO, ANPI, BEAT, ELNK and ARRS | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 04/08/2009 | 14h30 | PR Newswire (US) | Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 24/07/2009 | 16h56 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 23/07/2009 | 22h58 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 23/07/2009 | 21h59 | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 22/07/2009 | 14h29 | Marketwired | RothmanResearch.com Stock Review for INTU, CROX, ASTM, CINF, FRPT and ANPI | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 16/07/2009 | 18h51 | PR Newswire (US) | Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Libert (R) Long Stent | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 09/07/2009 | 14h21 | Marketwired | AnalystChoice.com Brings You the Best Complimentary Research Report on INFY, ANPI, SUSQ, ODFL, LSTR and CWTR | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 08/07/2009 | 22h13 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 08/07/2009 | 01h56 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 06/07/2009 | 14h30 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. announces conference call and webcast | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 25/06/2009 | 19h15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |